BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21762696)

  • 1. Mutant ubiquitin (UBB+1) associated with neurodegenerative disorders is hydrolyzed by ubiquitin C-terminal hydrolase L3 (UCH-L3).
    Dennissen FJ; Kholod N; Hermes DJ; Kemmerling N; Steinbusch HW; Dantuma NP; van Leeuwen FW
    FEBS Lett; 2011 Aug; 585(16):2568-74. PubMed ID: 21762696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain.
    Fischer DF; De Vos RA; Van Dijk R; De Vrij FM; Proper EA; Sonnemans MA; Verhage MC; Sluijs JA; Hobo B; Zouambia M; Steur EN; Kamphorst W; Hol EM; Van Leeuwen FW
    FASEB J; 2003 Nov; 17(14):2014-24. PubMed ID: 14597671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin dimers control the hydrolase activity of UCH-L3.
    Setsuie R; Sakurai M; Sakaguchi Y; Wada K
    Neurochem Int; 2009; 54(5-6):314-21. PubMed ID: 19154770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing substrate selectivity of ubiquitin C-terminal hydrolase-L3 using engineered α-linked ubiquitin substrates.
    Navarro MF; Carmody L; Romo-Fewell O; Lokensgard ME; Love JJ
    Biochemistry; 2014 Dec; 53(51):8031-42. PubMed ID: 25369561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation.
    Lindsten K; de Vrij FM; Verhoef LG; Fischer DF; van Leeuwen FW; Hol EM; Masucci MG; Dantuma NP
    J Cell Biol; 2002 Apr; 157(3):417-27. PubMed ID: 11980917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes.
    Dang LC; Melandri FD; Stein RL
    Biochemistry; 1998 Feb; 37(7):1868-79. PubMed ID: 9485312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease.
    van Tijn P; de Vrij FM; Schuurman KG; Dantuma NP; Fischer DF; van Leeuwen FW; Hol EM
    J Cell Sci; 2007 May; 120(Pt 9):1615-23. PubMed ID: 17405812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin C-terminal hydrolase-L3 regulates EMT process and cancer metastasis in prostate cell lines.
    Song HM; Lee JE; Kim JH
    Biochem Biophys Res Commun; 2014 Sep; 452(3):722-7. PubMed ID: 25194810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin binding interface mapping on yeast ubiquitin hydrolase by NMR chemical shift perturbation.
    Rajesh S; Sakamoto T; Iwamoto-Sugai M; Shibata T; Kohno T; Ito Y
    Biochemistry; 1999 Jul; 38(29):9242-53. PubMed ID: 10413498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease-associated ubiquitin mutant Ubb
    Munari F; Bortot A; Assfalg M; D'Onofrio M
    Int J Biol Macromol; 2018 Mar; 108():24-31. PubMed ID: 29175520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing polyubiquitinated forms of the neurodegenerative ubiquitin mutant UBB
    Chojnacki M; Zhang D; Talarowska M; Gałecki P; Szemraj J; Fushman D; Nakasone MA
    FEBS Lett; 2016 Dec; 590(24):4573-4585. PubMed ID: 27861798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low levels of mutant ubiquitin are degraded by the proteasome in vivo.
    van Tijn P; Verhage MC; Hobo B; van Leeuwen FW; Fischer DF
    J Neurosci Res; 2010 Aug; 88(11):2325-37. PubMed ID: 20336771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death.
    De Vrij FM; Sluijs JA; Gregori L; Fischer DF; Hermens WT; Goldgaber D; Verhaagen J; Van Leeuwen FW; Hol EM
    FASEB J; 2001 Dec; 15(14):2680-8. PubMed ID: 11726544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of the C-terminus of NEDD8 by UCH-L3.
    Wada H; Kito K; Caskey LS; Yeh ET; Kamitani T
    Biochem Biophys Res Commun; 1998 Oct; 251(3):688-92. PubMed ID: 9790970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Length of the active-site crossover loop defines the substrate specificity of ubiquitin C-terminal hydrolases for ubiquitin chains.
    Zhou ZR; Zhang YH; Liu S; Song AX; Hu HY
    Biochem J; 2012 Jan; 441(1):143-9. PubMed ID: 21851340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for Monitoring "Ubiquitin C-Terminal Hydrolase 1" (Yuh1) Activity.
    Saad S; Berda E; Klein Y; Issa S; Pick E
    Methods Mol Biol; 2023; 2602():107-122. PubMed ID: 36446970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The ubiquitin-proteasome system and neurodegeneration].
    Wada K; Osaka H; Aoki S; Wang YL
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1072-4. PubMed ID: 12235799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate.
    Misaghi S; Galardy PJ; Meester WJ; Ovaa H; Ploegh HL; Gaudet R
    J Biol Chem; 2005 Jan; 280(2):1512-20. PubMed ID: 15531586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of ubiquitin c-terminal hydrolases in oncogenesis.
    Fang Y; Fu D; Shen XZ
    Biochim Biophys Acta; 2010 Aug; 1806(1):1-6. PubMed ID: 20302916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate recognition and catalysis by UCH-L1.
    Luchansky SJ; Lansbury PT; Stein RL
    Biochemistry; 2006 Dec; 45(49):14717-25. PubMed ID: 17144664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.